Biomarkers in Drug Design
Indian Society for Clinical Organization, Tech Association of British Pharmaceutical Industry Researchers have been able to find an increasing number of critical molecular drivers of cancer growth thanks to advances in cancer molecular characterization. These drug discoveries have resulted in a number of novel anticancer therapies as well as scientific advancement in specific patient populations. Despite this, the identification of clinically meaningful response biomarkers is still a work in progress. We discuss methodologies for cancer molecular characterization and the role of biomarkers in the development of innovative anticancer treatments in this review.
Any new biomarkers discovered and evaluated should preferably adhere to the Clinical Laboratory Improvement Amendments (CLIA) and Good Clinical Laboratory Practice (GCLP) standards.
- Oncology and Infectious Diseases Medicine Development
- Drug Discovery Innovation and Strategies
- Drug discovery using computational chemistry and informatics